These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34435298)

  • 1. ASO Author Reflections: Identifying pCR After Neoadjuvant Chemotherapy: The Key to Treatment De-escalation in Breast Cancer.
    Lim DW; Hong NJL
    Ann Surg Oncol; 2022 Dec; 29(Suppl 3):570-571. PubMed ID: 34435298
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Moving Forward De-escalation of Axillary Surgery After Neoadjuvant Treatment in Breast Cancer.
    Rubio IT
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):638-639. PubMed ID: 30284130
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Disparities in Outcome and Surgical Management Following Neoadjuvant Chemotherapy for Breast Cancer.
    Relation T; Oppong BA
    Ann Surg Oncol; 2021 Oct; 28(11):6498-6499. PubMed ID: 33660126
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Neoadjuvant Chemotherapy Does Not Affect Short-Term Outcomes After Breast Cancer Surgery.
    Konishi T; Fujiogi M; Tanabe M; Seto Y; Yasunaga H
    Ann Surg Oncol; 2022 May; 29(5):3011-3012. PubMed ID: 34997419
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: The Role of Imaging Modalities in Omitting Surgery in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Palshof FK; Kroman N; Tvedskov TF
    Ann Surg Oncol; 2021 Nov; 28(12):7430-7431. PubMed ID: 34023947
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: How Can We Eliminate Breast Surgery in Patients Who Achieved Clinical Complete Response After Neoadjuvant Chemotherapy?
    Sawaki M; Kataoka A
    Ann Surg Oncol; 2023 Jun; 30(6):3233-3234. PubMed ID: 36765007
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Is It Worth the Risk? The Benefit of Neoadjuvant Chemotherapy in Elderly Patients with Breast Cancer.
    Williams AD; Barrio AV
    Ann Surg Oncol; 2022 Dec; 29(13):8012-8013. PubMed ID: 35941345
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Neoadjuvant Chemotherapy for Breast Cancer May Not Alter Increasing Trends for CPM Utilization.
    Christian N; Gemignani ML
    Ann Surg Oncol; 2020 Mar; 27(3):750-751. PubMed ID: 31728793
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy.
    Hieken TJ; Hoskin TL
    Ann Surg Oncol; 2022 Dec; 29(Suppl 3):597-598. PubMed ID: 35798892
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Avoiding an Axillary Lymph Node Dissection: The Benefit of Neoadjuvant Chemotherapy for Occult Primary Breast Cancer.
    Botty van den Bruele A; Plitas G; Pilewskie M
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):865-866. PubMed ID: 32725524
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: The Case for Using Response to Neoadjuvant Chemotherapy to Guide Administration of Post-mastectomy Radiation.
    Manik R; Fayanju OM
    Ann Surg Oncol; 2023 Oct; 30(11):6516-6517. PubMed ID: 37493891
    [No Abstract]   [Full Text] [Related]  

  • 12. ASO Author Reflections: Role of Genomic Assay to Predict Neoadjuvant Chemotherapy Response in Breast Cancer.
    Pease AM; James TA
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):573-574. PubMed ID: 30783852
    [No Abstract]   [Full Text] [Related]  

  • 13. ASO Author Reflections: Elimination of Breast Cancer Surgery in Complete Responders After Neoadjuvant Chemotherapy: Imaging Perspective.
    Rauch GM
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):628-629. PubMed ID: 30244417
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: Tailoring Axillary Surgery After Neoadjuvant Endocrine Therapy for Breast Cancer.
    Kantor O; King TA
    Ann Surg Oncol; 2021 Mar; 28(3):1368-1369. PubMed ID: 33389297
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflections: The Pursuit of Eliminating Surgery after Neoadjuvant Systemic Therapy in Breast Cancer Patients.
    van Loevezijn AA; van Duijnhoven FH; Vrancken Peeters MTFD
    Ann Surg Oncol; 2021 Jun; 28(6):3254-3255. PubMed ID: 33301068
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: How Predictive Models Can Help Guide Axillary Surgery Decision Making After Neoadjuvant Chemotherapy.
    Davis J; Boughey JC
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):690-691. PubMed ID: 32725523
    [No Abstract]   [Full Text] [Related]  

  • 17. ASO Author Reflections: Omission of Axillary Lymph Node Dissection for Breast Cancer Patients with Residual N1 Nodal Disease Following Neoadjuvant Chemotherapy: Not Ready for Primetime?
    Almahariq MF; Chen PY; Dekhne N; Dilworth JT
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):869-870. PubMed ID: 32737699
    [No Abstract]   [Full Text] [Related]  

  • 18. ASO Author Reflections: Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer: Is It Oncologically Safe?
    Piltin MA; Boughey JC
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):707-708. PubMed ID: 32737696
    [No Abstract]   [Full Text] [Related]  

  • 19. ASO Author Reflections: Postmastectomy Radiotherapy for Breast Cancer Patients After Neoadjuvant Chemotherapy, by Molecular Subtype.
    Ma JC; Zhong XR; Luo T; Liu L
    Ann Surg Oncol; 2021 Sep; 28(9):5096-5097. PubMed ID: 33604825
    [No Abstract]   [Full Text] [Related]  

  • 20. ASO Author Reflections: Nodal Downstaging and Conversion to Breast-Conserving Surgery Following Neoadjuvant Endocrine Therapy.
    Montagna G; Morrow M; Pilewskie M
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):693-694. PubMed ID: 32797378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.